As of September 30, 2024, Aimei Health Technology Co., Ltd. reported total assets of $72.8 million, reflecting an increase from $70.5 million at the end of 2023. However, current assets saw a significant decline, dropping to $123,900 from $580,717 as of December 31, 2023. The company’s cash and marketable securities held in the Trust Account rose to $72.7 million, up from $69.9 million at the end of the previous year.
Total current liabilities experienced a substantial increase, surging to $230,789 from $24,841 at the end of 2023. Consequently, total liabilities rose to $920,789, compared to $714,841 previously. The accumulated deficit also widened significantly, reaching $(797,102) as of September 30, 2024, compared to $(134,337) at the end of 2023.
In terms of profitability, Aimei Health reported a net income of $743,510 for the three months ended September 30, 2024, a notable improvement from no income during the same period in 2023. For the nine months ended September 30, 2024, the company achieved a net income of $2.1 million, a substantial turnaround from a net loss of $(3,618) for the corresponding period in the previous fiscal year. Interest earned on investments held in trust for the nine months totaled $2.8 million.
As of September 30, 2024, Aimei Health had $103,559 in its operating bank account and reported a working capital deficit of $106,889. The company has not yet commenced any operations and is currently focused on identifying a target for a business combination. A significant strategic development occurred with the signing of a definitive Business Combination Agreement on June 19, 2024, with United Hydrogen Group Inc.
About Aimei Health Technology Co., Ltd.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.